Sorin Group has announced that it is to make a $20 million minority investment in Respicardia, a developer of implantable therapies to improve Respiratory Rhythm Management™.
Cardio
Cardica Adds New Curved Tip to Microcutter XCHANGE® 30 Surgical Stapler
Cardica, Inc. has unveiled a curved tip cartridge for its MicroCutter XCHANGE® 30 surgical stapling device, which is designed to facilitate placement of the stapler on selected tissues.
CE Mark for Boston’s Pacemaker Opens MRI Conditionality Options
When implanted with Boston Scientific’s INGEVITY™ leads, Boston Scientific’s ACCOLADE pacemakers are the first to enable patients to receive full-body MRI scans in both 1.5 Tesla and 3.0 Tesla systems.
Pacing Lead Approval for MR-Conditional Use in Bradycardia Patients
The U.S. FDA has approved Medtronic’s CapSureFix Novus™ MRI SureScan® 5076 Lead for use with magnetic resonance imaging.
CoreValve Safe and Effective for Direct Aortic Approach
Study of 100 patients demonstrated low rates of mortality, stroke and paravalvular leak at 30 days.
Study Shows 95.5% 3 Year Freedom from Valve-Related Death with Sorin’s Freedom Solo
Sorin Group is touting the results of the European and North American (Canada and US) cohort study on the Freedom Solo valve.
Trials and Economics Support Sorin’s Perceval Sutureless Valve
Sorin Group has announced the results of the Perceval CAVALIER Trial and of the Pooled European Multicenter Experience at this week’s 28th EACTS Congress
Third Time Lucky as FDA Panel Votes Yes to WATCHMAN™ LAA Device
Expert Panel review has culminateded in a vote in favour of Boston Scientific Corporation’s WATCHMAN™ Left Atrial Appendage Closure Device.
First Human Use of CardiacAssist PROTEK DUO™ Veno-Venous ECLS Kit
CardiacAssist’s PROTEK Duo veno-venous extracorporeal life support (VV ECLS) kit has been used in a human for the first time.
First U.S. Implant of Sorin’s Solo Smart Stentless Valve
The first U.S. implantation of Sorin’s Solo Smart aortic valve represents a first removable stent valve procedure in the country.
TAVR: First Patient Treated in U.S. Cerebral Protection Pivotal Trial
Randomized controlled SENTINEL Trial is the first in the U.S. to study capture and removal of debris released during TAVR that may otherwise be the source of stroke
CE Mark for Direct Flow Medical’s Enhanced Transfemoral TAVI Delivery System
Direct Flow Medical®, Inc., has received the CE Mark for an enhanced transfemoral delivery system for its Transcatheter Aortic Valve System.
St. Jude Pacing Leads Now CE Marked as MRI Friendly
St. Jude Medical, Inc. has gained CE Mark approval that will allow patients fitted with its Tendril™ STS and IsoFlex™ Optim™ pacing leads, to undergo MRI scans.
Tangled Web Sees ICD Inventor Awarded $309 Million for now
The family of the man who helped invent the ICD has been awarded $309 million against Boston Scientific, although appeals loom.
Novate’s Sentry™ IVC Filter Study Sees First Patient
Novate’s novel bioconvertible Sentry™ Inferior Vena Cava (IVC) Filter is being put to the test in the SENTRY IDE Study. A first patient has now been treated.
New Study into Myocardial Tissue Repair with Stem Cells
Agreement will see safety and efficacy study into stem cells delivered by BioCardia’s Helix Transendocardial system